RoseVilla launches sustainable senior campus expansion in Portland
Abbott Announces New Diabetes Drug Trial Results
Sanofi Foundation deepens support for youth
OPTAR Expands into New Drug Targets
AI IDs New Drug Target in Solid Tumors
SAE Media to Host AI Drug Discovery Conference

Senior housing execs debate middle-market affordability
Blake Management Group boosts senior living profits through tight cost

Senior Housing Shifts Focus to Profit Margins

Canada Senior Housing Market Surges Ahead
Ingleside Meadowood, Lenbrook Announce Leadership Transitions
Senior living firm targets healthspan gap with science-backed programs
HumanGood targets the healthspan gap with science-backed programs to help seniors live longer in good health, addressing a trillion-dollar opportunity.
Community Partnerships Drive Hepatitis C Elimination in England
Community partnerships drive hepatitis c elimination in England, bridging medical innovation with trusted channels to improve patient access.
Clinical Trials Risk Losing Patients Due to Operational Errors
Clinical trials risk losing patients due to operational errors, impacting enrolment and research progress.
Manchester NHS and MHRA launch sandbox for real-world tech testing
Manchester NHS and MHRA launch sandbox for real-world tech testing with AI-enabled medical devices.
Partnership Boosts Shared Decision-Making in Rare Diseases
Shared decision making improves rare disease care as a partnership program honors collaborations between UK health providers and life‑science firms.
AI platform accelerates discovery of cancer drug candidates
New AI-driven platforms are revolutionizing cancer drug discovery by utilizing 3D bioprinting to test patient-specific therapies with high-speed imaging.
From Tension to Balance: How Regular Massage Can Transform Your Posture and Energy
Combine Methods to Improve Results for Increasing Penis Length and Girth
The Best Products for Diamond Ring Cleaning and Maintenance

Touchmark Starts Work on Alaska Senior Living Project

CEPI funds African vaccine for Bundibugyo ebolavirus

NHS shifts care to community services
Europe unveils continuous manufacturing breakthrough for drugs
Europe’s PIPAC initiative revolutionizes drug production with AI-driven continuous manufacturing, cutting resource use and scaling time for APIs.
New non-opioid painkillers approach developed
New non-opioid painkillers approach developed from cone snail venom. Researchers discover peptide AoIA reduces inflammation-induced pain safely without opioid r
New drug wipes out lingering leukemia cells
A breakthrough drug achieves 70% remission in high-risk leukemia patients by wiping out lingering cancer cells for longer survival.
Latest News
X-ray Inspection Returns to Core Pharma Production
X-ray inspection has become essential in pharmaceutical quality control, providing a non-destructive method to confirm product integrity without…
Cancer therapy breakthroughs offer new hope
Cancer therapy breakthroughs offer new hope with photothermal therapy advancements, overcoming major hurdles in treatment options, offering improved…
AI speeds peptide drug discovery process
AI speeds peptide drug discovery process with PeptiVerse platform predicting key properties.
Half of US adults now eligible for statins
New guidelines recommend statins for half of US adults ages 30 to 79 to prevent cardiovascular disease. Learn…
U.S. statin guidelines expand eligibility for millions
New U.S. statin guidelines expand eligibility for 87.5 million adults aged 30-79 to prevent cardiovascular disease, per updated…
Abbott Announces New Diabetes Drug Trial Results
Abbott reveals promising outcomes from its latest diabetes drug trial, showing improved blood sugar control and a strong…
Sanofi Foundation deepens support for youth
Sanofi Foundation deepens support for youth facing health challenges, climate issues, and humanitarian crises beyond healthcare access.
GLP-1 Diabetes Drugs May Raise Hair Loss Risk
GLP-1 hair loss risk rises for type 2 diabetes patients using GLP-1 receptor agonists, with a 37% higher…
New Degrader Technology Targets Cancer Cells Selectively
The new cancer degrader technology from Technion researchers selectively destroys aggressive tumor cells, offering an advance in cancer…
OPTAR Expands into New Drug Targets
OPTAR expands into new drug targets with a computational tool for discovering novel therapeutic targets from large-scale omics…